NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Martin Bionics

Martin Bionics

Private
Oklahoma City, OklahomaHealthcare & Life Scienceshttps://martinbionics.com/

Last Round

Debt

Apr 15, 2020

Total Funding Raised

$345,000

Company Overview

Martin Bionics is a medical device company that develops and manufactures adjustable, modular prosthetic socket systems designed to improve comfort and mobility for individuals with limb loss.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

prosthetic socketprosthetic interfacesocket-less socketprostheticsadjustable prostheticprosthetic componentsprosthetic fittingamputee mobilityprosthetic clinical trainingcustom prostheticsbionic compositesprosthetic suspensionmedical device manufacturerO&Porthotics and prosthetics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Martin Bionics Comparables

Compare Martin Bionics with similar companies based on industry and business-model similarity.

Martin Bionics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LIM Innovations
92%
Click Medical
88%
iFIT Prosthetics
83%

Martin Bionics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtApr 15, 2020
AcceleratorJan 1, 2019

Key People

Founding team and executive leadership

Carsten Pedersen

Chief Executive Officer

Executive Team

Seth Reiter

Chief Operating Officer

Executive Team

Martin Bionics Investors

Notable investors and investment history

Martin Bionics investors
InvestorRounds
PraxisAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 22, 2025

    Grew 18% QoQ, from 39 to 46 employees.

Martin Bionics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Martin Bionics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Martin Bionics's valuation, stock price, and market status.

Firmographic Details

HeadquartersOklahoma City, Oklahoma
Employee Range45
Year Founded2009
Last FundingApr 15, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.